Monitor the actual 10-Q filing within the next five calendar days for the impact of the foreign currency exchange adjustments and any resulting changes to reported results.
CTSO drugs
CTSO drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 17 $4.52entry
- T+1 · 4d ago +23.12%α +23.43% · $5.57
- T+3 · todayOpen
- T+5 · tomorrow Pending
- T+20 · in 24d Pending
- T+60 · in 3mo Pending
Price Chart
Executive Summary
CytoSorbents Corp filed an NT 10-Q stating it cannot timely file its Form 10-Q for the quarter ended September 30, 2026, due to needing additional time to work with its auditor on evaluating non-cash foreign currency exchange gains and losses. The company expects to file within five calendar days of the prescribed due date. The filing does not mention a restatement or auditor change, and no prior NT filing is noted in the provided context.
Key Facts
- NT 10-Q filed November 17, 2026 for the quarter ended September 30, 2026
- Reason: additional time needed to evaluate non-cash foreign currency exchange gains and losses with the auditor
- Company expects to file within five calendar days of the prescribed due date
- No prior NT filing from this company in the provided context
- No mention of restatement or auditor change in the filing
- Market cap is $17M; normal daily move is 10.5%
Financial Impact
No financial figures provided; the delay relates to non-cash foreign currency exchange gains and losses, which could affect reported earnings but the magnitude is undisclosed.
Risk Factors
- The late filing could trigger Nasdaq listing compliance concerns if it becomes a pattern
- The foreign currency exchange adjustment may materially affect reported earnings, but no estimate is provided
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| NT 10-Q Filing (Primary) | 0001104659-26-128801 |
| Document: 0001104659-26-128801-index-headers.html | 0001104659-26-128801 |
| Document: 0001104659-26-128801-index.html | 0001104659-26-128801 |
| Document: 0001104659-26-128801.txt | 0001104659-26-128801 |
Track record
12 reports on CTSO
2 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +36.94% at T+60 after the Aug 6, 2026 report. 2 of 3 went positive at some point.
Filters
- Nov 20, 20261d ago 424B5 Bearish 6/10 Entry $5.39 Now $4.16 +22.82% settles Feb 19
- Nov 20, 20261d ago 8-K Bearish 6/10 Entry $5.39 Now $4.16 +22.82% settles Feb 19
- Nov 19, 20263d ago 8-K/A Neutral 4/10 Entry $5.13 Now $4.16 −18.91% settles Feb 18
- Nov 17, 20265d ago NT 10-Q Neutral 4/10 Viewing Entry $4.52 Now $4.16 −7.96% settles Feb 16
- Nov 12, 20269d ago Press Release Neutral 4/10 Entry $4.87 Now $4.16 −14.58% settles Feb 11
- Nov 12, 20269d ago 8-K Neutral 5/10 No price data
- Sep 23, 20268w ago 8-K Mixed 5/10 Entry $4.91 Now $4.16 −15.27% settles Dec 17
- Aug 6, 202615w ago Press Release Bearish 6/10 Entry $0.3600 to $0.2270 Now $4.16 −1055.56% ▲ +36.94% +34.68% vs SPY
- Jun 25, 202621w ago DEFA14A Neutral 3/10 Entry $0.3620 to $0.2660 Now $4.16 +1049.17% ▼ −26.52% −32.61% vs SPY
- Jun 16, 202622w ago Insider Cluster Bullish 6/10 Entry $0.5189 to $0.3205 Now $4.16 +701.70% ▼ −38.23% −40.10% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers